ESSURE
FDA premarket approval P020014/S040 · decided 2013-10-30
Approval details
- PMA number
- P020014
- Supplement
- S040
- Supplement type
- Special (Immediate Track)
- Supplement reason
- Labeling Change - Indications/instructions/shelf life/tradename
- Trade name
- ESSURE
- Generic name
- Transcervical contraceptive tubal occlusion device
- Applicant
- Bayer Pharma AG
- Date received
- 2013-10-03
- Decision date
- 2013-10-30
- Days to decision
- 27 days
- Decision code
- APPR
- Product code
- HHS
- Advisory committee
- Obstetrics/Gynecology
- Expedited review
- No
- Location
- Berlin
- Statement
- APPROVAL FOR CHANGES TO THE PATIENT INFORMATION BOOKLET TO INCLUDE ADDITIONAL INFORMATION ON RISKS OF CHRONIC PELVIC PAIN AND DEVICE MIGRATION.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.